Cargando…
Subnormal Growth Velocity and Related Factors During GnRH Analog Therapy for Idiopathic Central Precocious Puberty
OBJECTIVE: Data concerning subnormal growth velocity (GV) and factors that influence this during gonadotropin-releasing hormone analog (GnRHa) therapy for idiopathic central precocious puberty (ICPP) are scarce. We investigated the incidence of subnormal GV and associated factors in patients receivi...
Autores principales: | Muratoğlu Şahin, Nursel, Uğraş Dikmen, Asiye, Çetinkaya, Semra, Aycan, Zehra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083469/ https://www.ncbi.nlm.nih.gov/pubmed/29687783 http://dx.doi.org/10.4274/jcrpe.0023 |
Ejemplares similares
-
Evaluating the Efficacy of Treatment with a GnRH Analogue in Patients with Central Precocious Puberty
por: Kendirci, H. Nur Peltek, et al.
Publicado: (2015) -
Challenges in monitoring GnRH analog treatment in central precocious puberty
por: Latronico, Ana Claudia
Publicado: (2020) -
Treatment of central precocious puberty using low dose GnRH analogs (GnRHa)
por: Jahagirdar, Rahul, et al.
Publicado: (2015) -
Investigation of MKRN3 Mutation in Patients with Familial Central Precocious Puberty
por: Aycan, Zehra, et al.
Publicado: (2018) -
Gonadotropin-releasing hormone (GnRH) stimulation test before and after GnRH analogue treatment in central precocious puberty; can GnRH test simplify adequately?
por: Yang, You Jean, et al.
Publicado: (2013)